Within the tumultuous seas of the stock market, value investing stands as a stalwart lighthouse, guiding investors towards hidden gems waiting to be unearthed. Historically championed by luminaries such as Warren Buffett, this approach involves seeking out stocks that are undervalued compared to their intrinsic worth.
In the current landscape of the U.S. stock market, concern looms large like a shadow cast by towering skyscrapers. The Shiller P/E Ratio for the S&P 500 paints a worrisome scene, standing at 35.82, a figure more than double its historical average of 17.14. This metric, which pits stock prices against inflation-adjusted earnings over the past decade, implies that the broader market may be standing on shaky ground in terms of valuation.
Image Source: Getty Images.
Armed with this backdrop, let’s delve into three value stocks that are shimmering like hidden treasures beneath the surface, just waiting for intrepid investors to seize the opportunity.
Unlocking Value with Viatris
Viatris (NASDAQ: VTRS), a global healthcare entity forged through the amalgamation of Mylan and Upjohn, a former arm of Pfizer, specializes in both generic and branded medicines. The company finds itself in the midst of a value oasis, with its stock trading at a forward price-to-earnings (P/E) ratio of a mere 4.33, a stark contrast to the industry average of 17. Despite grappling with turbulence since its inception due to pricing challenges surrounding small molecule generic drugs, Viatris remains steadfast.
Bolstering its allure, Viatris also bestows upon its shareholders a generous dividend yield of 4.12%. While Wall Street anticipates a slight dip of 1.5% in revenue for the drugmaker in 2025 due to persistent price erosion in the generic-drug sector, the company’s potential lies in its ability to revamp its product portfolio and harness value from its innovative drug pipeline. Viatris may be a tale of turnaround, but the underlying potential hints at a promising horizon for those willing to navigate the long-term route.
Ford Motor Company: Driving Towards Transformation
Ford Motor Company (NYSE: F), an iconic name in the automotive realm, is embarking on a profound journey towards electric vehicles (EVs). Trading at a forward P/E ratio of 5.39, Ford stocks offer a tantalizing 5.71% yield. Despite projections for modest top-line growth of 1.1% in 2025, reflecting the hurdles of transitioning to EVs amid recent manufacturing hiccups, Ford stands as a narrative of resurgence.
The metamorphosis into EVs and a strategic pivot towards its most lucrative segments position Ford as a phoenix ready to rise from the ashes. While the road to recovery may be winding, those who navigate it with Ford might relish substantial rewards over the coming decades. In a market sweltering with hype, Ford emerges as a refreshing oasis of value for discerning investors.
Ally Financial: Navigating the Digital Frontier
Ally Financial (NYSE: ALLY), a digital financial services stalwart offering a spectrum of products encompassing auto financing, online banking, and investment services, presents a compelling value proposition. With a forward P/E of 13.4, below the industry average, and a robust dividend yield of 2.88%, Ally is projected to flaunt vigorous top-line growth of 12.7% in 2025. While the catalyst behind this revenue surge remains somewhat enigmatic, Ally’s digital-first approach heralds a future with reduced overhead costs compared to traditional banking establishments.
However, the specter of an economic downturn could cast a shadow, particularly impacting loan performance within the auto sphere. Thus, Ally Financial beckons not to the fainthearted traders seeking fleeting gains but to value investors fortified to navigate through the undulating waves of multiple business cycles.
Dive Deeper: Key Takeaways
While these three value stocks may not promise instantaneous portfolio alchemy, each company shines with strong fundamentals, weathering storms while poised for endurance. Viatris, Ford, and Ally, each carrying their unique narratives, offer a compelling case for investors seeking alternatives beyond the glitz and glamor of the current market rhythm.
Should you invest $1,000 in Viatris right now?
Before rushing into the depths of Viatris stock, it’s prudent to pause and reflect:
